Clinical trial
Open Label Extension Study of AMG 531 in Japanese Subjects With ITP
NCT00440037 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00440037 |
|---|---|
| Title | Open Label Extension Study of AMG 531 in Japanese Subjects With ITP |
| Official title | An Open Label Extension Study Evaluating the Safety and Efficacy of Long Term Dosing of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic Purpura |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Immune (Idiopathic) Thrombocytopenic Purpura (ITP) |
| Intervention type | Biological |
| Interventions | AMG 531 |
| Enrollment | 44 |
| Start date | Nov 1, 2006 |
| Primary completion | Jul 1, 2011 |
| Completion | Sep 1, 2011 |
| First posted | Feb 26, 2007 |
| Last update posted | Jan 21, 2020 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: